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Epithelial ovarian cancer constitutes a great healthcare issue with a high mortality. 
Therapeutic options depend on the extensiveness of the disease. Surgical removal of all 
visible tumour sites is the treatment of choice whereas chemotherapy is used as 
alternative when resection is deemed not viable or impossible. Ultrasound and 
computed tomography (CT) are the backbone of ovarian cancer diagnosis and 
characterization. However, other techniques such as magnetic resonance imaging (MRI) 
and positron emission tomography (PET) are being investigated for diagnostic purposes. 
In this thesis we evaluate how we can use existing and novel imaging strategies to 
optimally guide treatment decisions with the objective to improve long term outcome 
of patients with ovarian cancer. Chapter 1 provides a general introduction and 
introduces the research questions which form the outline of this thesis.  
In part I of this thesis we have used information on skeletal muscle derived from 
standard CT scans as predictive factors in retrospective ovarian cancer survival analyses. 
In Chapter 2 we studied advanced ovarian cancer patients (n=123) treated with interval 
debulking surgery and investigated whether changes in skeletal muscle were related to 
overall survival. We measured surface areas of skeletal muscle on CT scans which were 
taken before and after treatment with neoadjuvant chemotherapy and compared 
patients that maintained or gained skeletal muscle with patients that lost skeletal 
muscle during chemotherapy. Patients with skeletal muscle gain had a significantly 
better median overall survival of 1431 days compared to patients with skeletal muscle 
loss who had a median overall survival of 916 days (p=0.004). The predictive influence 
of skeletal muscle loss was confirmed in multivariable Cox-regression analysis. In this 
patient group, a skeletal muscle index lower than the median skeletal muscle index at 
the baseline CT scan before treatment with chemotherapy was not predictive of 
prognosis. In Chapter 3 we studied our second patient cohort which consisted of 216 
patients treated with primary debulking surgery. In this group only a single pre-
treatment CT scan was available for analysis. Instead of using the median SMI at 
baseline we performed optimum stratification to find the optimal skeletal muscle index 
cut-off to define sarcopenia, severe skeletal muscle loss. The aims of the study were to 
investigate if sarcopenia was associated with overall survival and if sarcopenia was 
associated with surgical complications. We found that sarcopenia was neither predictive 
of overall survival nor of surgical complications in ovarian cancer patients undergoing 
primary debulking surgery. However a strong trend towards a survival disadvantage for 
patients with sarcopenia was seen but other predictors such as completeness of 
surgery, treatment in a specialized centre and the development of major surgical 
complications showed a stronger relationship with overall survival. The effect of 
sarcopenia on overall survival may be more prominent when studied in a larger cohort 
of patients. To conclude part I we investigated whether assessment of psoas muscle 
area reflects total muscle area in Chapter 4. If so, measuring the psoas muscle area 
alone instead of the total skeletal muscle area on CT could be a quick and easy method 
to identify sarcopenia. To answer this question we quantified the psoas muscle with two 
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methods; firstly with imaging software and secondly manually by measuring the length 
and width of this muscle. We compared this to quantifications of total muscle area in 
150 ovarian cancer patients treated with interval debulking surgery. The correlation 
between total skeletal muscle area and both psoas area measurement methods was 
poor. After categorizing patients into muscle loss or gain, kappa agreement was also 
poor for comparison between total skeletal muscle area and either methods of psoas 
area. We concluded that a change in psoas muscle area was not representative of a 
change in total muscle area. Measurement of psoas area should not be used to 
substitute measurement of total skeletal muscle area to predict sarcopenia and survival 
in patients with ovarian cancer.   
In part II we explored how accurate CT-based prediction models are to predict 
outcome of primary debulking surgery and we considered two new imaging techniques 
for the prediction of resectability: diffusion-weighted magnetic resonance imaging (DW-
MRI) and combined positron emission tomography magnetic resonance imaging 
(PET/MRI). In Chapter 5 three prospectively developed CT prediction models for 
incomplete surgery (any tumour residual > 1 cm in diameter) by Ferrandina (models A 
and B) and by Gerestein were applied to a validation cohort consisting of 151 patients 
with advanced epithelial ovarian cancer. All three models showed a limited 
discriminative ability and the reproducibility of the models was questionable. The 
models were not sufficiently reliable for clinical decision making. A radiologist’s 
subjective assessment was as accurate as using a prediction model. The high 
importance of selecting patients who will benefit from primary debulking surgery in 
combination with the limited performance of CT encouraged us to investigate novel 
diagnostic modalities in the prediction of ovarian cancer resectability. In Chapter 6 we 
investigated the diagnostic accuracy of PET/MRI and DW-MRI in comparison with CT for 
the assessment of surgical resectability. In this prospective pilot study, six patients 
treated with primary debulking surgery and four patients treated with neoadjuvant 
chemotherapy and interval debulking surgery were subjected to standard CT scans and 
a combined PET/MRI scan with DW-MRI. The two novel methods showed a trend 
towards an improved sensitivity compared to CT in the detection of peritoneal tumour 
deposits. However, the results for PET/MRI were mainly a reflection of the contribution 
of MRI; FDG accumulation was not present in the majority of (small) intraperitoneal 
tumour sites and PET imaging could not be used reliably to predict negative tumour 
sites. The predictive value of DW-MRI regarding ovarian cancer resectability in 
comparison to CT has shown promise in recent studies and deserves further 
investigation in larger prospective trials. A higher diagnostic performance is expected 
with optimization of the DW-MRI scan protocol on dedicated MRI devices.  
Part III of the thesis was dedicated to investigating the value of ultrasound and MRI 
techniques in the characterization of adnexal tumours. Correct differentiation is 
essential for further treatment decisions. In Chapter 7 we provide the results of our 
meta-analysis in which we evaluated the diagnostic performance of contrast-enhanced 
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MRI and DW-MRI for differentiation between benign and malignant adnexal masses. 
Thirty-eight datasets were included which resulted in good diagnostic accuracy for 
contrast-enhanced MRI with a sensitivity of 91% and a specificity of 89%. A high pooled 
sensitivity and specificity was also found for DW-MRI with a trend towards an improved 
diagnostic accuracy compared to MRI. More prospective studies establishing the added 
value of DW-MRI are still desired. A different strategy towards improving the 
characterization of adnexal masses incorporating DW-MRI was therefore proposed in 
Chapter 8 in which we provide the protocol for the prospective multi-centre cohort 
study SUBSONiC. The International Ovarian Tumour Analysis (IOTA) group successfully 
developed ten ultrasound rules to characterize an adnexal mass: the Simple Rules. 
Subjective assessment of an expert sonographer is known to improve the accuracy of 
adnexal ultrasound further. Our aim was to test the value of a two-step triage test 
consisting of 1) the Simple Rules, supplemented with 2) subjective assessment by an 
expert sonographer or DW-MRI in the differentiation between benign and malignant 
adnexal masses. This triage test was compared with current clinical practice in which 
the Risk of Malignancy Index is applied. This index incorporates five ultrasound 
variables, the menopausal status and serum CA-125 to predict the likelihood that an 
adnexal mass is malignant but results in an incorrect diagnosis in around 20% of 
patients. We hypothesized that implementation of the two-step triage test would result 
in a better diagnostic accuracy than use of the Risk of Malignancy Index. In Chapter 9 we 
report the results of our interim analysis in which we analyzed one of the secondary 
objectives of the SUBSONiC study, the interobserver variability between the primary 
ultrasound executed by an untrained examiner and the subjective assessment of the 
expert ultrasound executed by an examiner trained in the interpretation of the Simple 
Rules. The interim analysis provided data for the first 50 consecutive women enrolled in 
the SUBSONiC study. Frequent misclassification of the tumour type and misinter-
pretation of the Simple Rules by untrained examiners resulted in a poor interobserver 
agreement and an incorrect diagnosis (benign, malignant or inconclusive) in 30% of the 
patients when compared to the diagnosis made by the expert examiner. Due to the high 
rates of mistakes found at the interim analysis in both the use of IOTA terminology and 
application of the Simple Rules, the SUBSONiC study has been halted until further 
notice. Training programmes for gynaecologists and gynaecological residents are 
necessary before the SUBSONiC study can be restarted and before assumptions can be 
made about the diagnostic performance of the model.   
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